TCT 2019 | STS/ACC TVT Registry: Relationship Between MitraClip Operator Experience and Events

Courtesy of SBHCI.

Mitral valve repair with a MitraClip device is a complex procedure that requires that operators develop a series of skills that may be unusual for them, such as analyzing an echocardiography.

Highlights TCT 2019

In this registry, researchers assessed the relationship between operator experience and procedural outcome.

Operators were classified into 3 groups: 1 to 25 procedures conducted, 26 to 50 procedures conducted, and 50+ procedures conducted. Researchers assessed the rates of procedural success, procedural time, and in-hospital complications.

The study analyzed 14,923 MitraClip procedures conducted by 562 operators in 290 sites. Optimal success rates (regarded as mitral regurgitation grade 1 or less) increased alongside operator experience (63.9%, 68.4%, and 75.1%, respectively; p < 0.0001). Acceptable success rates (regarded as regurgitation grade 2 or less) also increased alongside the number of procedures conducted (91.4%, 92.4%, and 93.8%; p < 0.001).

The cutoff point as regards the success rate and the rate of complications was clear at 50 procedures, but outcomes continued improving up to 200 procedures.

Courtesy of SBHCI.

Link to the SBHCI publication HERE

Original Title: STS/ACC TVT Registry: MitraClip Operator Volume-Outcome Relationship in the United States.

Author of the original title: Adnan K. Chhatriwalla.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

Coronary artery disease progression after transcatheter aortic valve replacement: quantitative coronary angiography and Quantitative Flow Ratio analysis

The coexistence of coronary artery disease and severe aortic stenosis is common among patients undergoing transcatheter aortic valve replacement (TAVR). However, the impact of...

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...